C

Á

CAMACHO , Ángela

Last name: CAMACHO

First name: Ángela

July 2, 2021 (v1)

Publication

Metadata-only

Differences in HCV Viral Decline between Low and Standard-Dose Pegylated-Interferon-Alpha-2a with Ribavirin in HIV/HCV Genotype 3 Patients

Rivero-Juarez, Antonio López Cortés, Luis Fernando Camacho, Ángela

Background: The aim of the study was to analyze the different impact of standard and low-dose Peg-IFN-a2a/RBV therapies on HCV viral decline in HIV/HCV genotype 3 co-infected patients during the first weeks of treatment. Methods: Plasma HCV viral decline was analyzed between baseline and weeks 1, 2 and 4 in two groups of treatment-naı¨ve HCV...

Uploaded on: December 4, 2022